NasdaqGS - Nasdaq Real Time Price USD
Myriad Genetics, Inc. (MYGN)
At close: November 15 at 4:00 PM EST
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| ANCONA MARGARET Officer | Sale | Aug 21, 2024 | 79,366 |
| BISARO PAUL M. Director | Stock Award(Grant) | Jun 6, 2024 | 40,145 |
| DIAZ PAUL J Chief Executive Officer | Sale | Oct 11, 2024 | 962,378 |
| DREISMANN HEINRICH PH.D. Director | Sale | Sep 9, 2024 | 121,648 |
| FOX JENNIFER LYNNE Officer | Stock Award(Grant) | Sep 3, 2024 | 61,771 |
| KUMAR RASHMI Director | Sale | Aug 19, 2024 | 77,392 |
| MUZZEY DALE Officer | Sale | Sep 11, 2024 | 108,013 |
| PHANSTIEL S LOUISE Director | Stock Award(Grant) | Jun 6, 2024 | 160,767 |
| REITAN COLLEEN F. Director | Sale | Sep 3, 2024 | 42,533 |
| SKOVRONSKY DANIEL M. Director | Stock Award(Grant) | Jun 6, 2024 | 86,010 |
Related Tickers
CDNA CareDx, Inc
21.17
-1.76%
NEOG Neogen Corporation
14.60
-0.27%
VCYT Veracyte, Inc.
35.94
-2.97%
QGEN Qiagen N.V.
41.27
-1.95%
SHC Sotera Health Company
14.31
-4.54%
RVTY Revvity, Inc.
109.52
-5.63%
NEO NeoGenomics, Inc.
15.04
-4.75%
DGX Quest Diagnostics Incorporated
160.44
+2.30%
GH Guardant Health, Inc.
29.11
-3.64%
CRL Charles River Laboratories International, Inc.
187.74
-4.65%